Jennings Eric, Hall Brad
Woolfson Eye Institute, Atlanta, GA, USA.
Sengi, Penniac, NB, Canada.
Clin Ophthalmol. 2024 Sep 17;18:2605-2609. doi: 10.2147/OPTH.S481797. eCollection 2024.
To evaluate the efficacy of a cloud-based surgical planning platform with regards to refractive target accuracy.
This was a retrospective chart review of consecutive cases from January 2022 through December 2023. Surgical planning was performed using the SMARTCataract platform, eyes were implanted with Clareon monofocal IOLs, and power calculations were done using the Barrett Universal II formula. Data were collected for the percentage of eyes within ±0.5 D of target refraction, mean absolute error (MAE), and postoperative visual acuity.
A total of 148 eyes were identified that met the inclusion/exclusion criteria. The percentage of eyes within ±0.5 D of the planned target was 94%. The MAE was 0.25 ± 0.17 D. In addition, 57%, 93%, 98%, and 100% of eyes had MAE ≤ 0.25 D, ≤ 0.5 D, ≤ 0.75 D, and ≤ 1.0 D, respectively.
The results of this study suggest high refractive accuracy when using the SMARTCataract planning platform with the Barrett Universal II formula and excellent distance visual acuity.
评估基于云的手术规划平台在屈光目标准确性方面的疗效。
这是一项对2022年1月至2023年12月连续病例的回顾性图表审查。使用SMARTCataract平台进行手术规划，为眼睛植入Clareon单焦点人工晶状体，并使用Barrett Universal II公式进行屈光度计算。收集目标屈光±0.5 D范围内眼睛的百分比、平均绝对误差（MAE）和术后视力数据。
共确定148只眼睛符合纳入/排除标准。计划目标±0.5 D范围内眼睛的百分比为94%。MAE为0.25±0.17 D。此外，分别有57%、93%、98%和100%的眼睛MAE≤0.25 D、≤0.5 D、≤0.75 D和≤1.0 D。
本研究结果表明，使用SMARTCataract规划平台和Barrett Universal II公式时屈光准确性高，且远视力良好。
